Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 6Phase 1/2 2

Status

Completed 5Terminated 1

Sponsor Class

NIH 3OTHER 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Lymphoma 10Breast Neoplasms 10Leukemia 9Carcinoma, Ovarian Epithelial 8Ovarian Neoplasms 7Multiple Myeloma 7Prostatic Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Myelodysplastic Syndromes 6Melanoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Astrocytoma 6Lymphoma, Follicular 5Lung Neoplasms 5Brain Neoplasms 5Oligodendroglioma 4Neoplasms, Plasma Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hodgkin Disease 4

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × sargramostim × Clear all
NCT02250014 2022-02-09

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

University of Colorado, Denver

Phase 1 Completed
19 enrolled
Genitourinary

Prostatic Neoplasms

NCT00064129 2020-07-30

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT00113984 2019-12-16

Vaccine and Antibody Treatment of Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT00023634 2015-03-06

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

SWOG Cancer Research Network

Phase 1 Terminated
14 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Astrocytoma, Brain Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00305669 2014-06-25

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

University of California, San Francisco

Phase 1 Completed
24 enrolled
Genitourinary

Prostatic Neoplasms

NCT00004029 2013-02-11

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
46 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡